Stay updated with breaking news from Named Patient Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ZURICH, SWITZERLAND / ACCESSWIRE / December 29, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company, focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system...
Zürich, Switzerland, December 29, 2023 - NLS Pharmaceutics Ltd. , a Swiss clinical-stage biopharmaceutical company, focused on the discovery and development of innovative therapies for...
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...
HONG KONG, Jan. 9, 2023 /PRNewswire/ -- Luye Pharma's Innovative Anti-Cancer Therapy Lurbinectedin to Benefit
Investegate announcements from NLS Pharmaceutics AG, NLS Pharmaceutics Issues Letter to Shareholders